FdaApplication
NDA 209963
Identifiers
- fda_app_no: NDA209963
Properties
| Property | Value |
|---|---|
| applicant_name | LXO IRELAND DESIGNATED ACTIVITY CO |
| application_type | NDA |
| approval_date | 2017-12-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GOPRELTO | COCAINE HYDROCHLORIDE | 4% | SOLUTION;NASAL |
1 product